Dr. Chiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
# 141
New York, NY 10065Phone+1 212-746-6000Fax+1 646-962-0122
Summary
- NIH-funded physician-scientist developing PET and MR imaging tools to better diagnose and monitor Alzheimer's and other neurodegenerative diseases.
Education & Training
University of California (San Francisco)Fellowship, Neuroradiology, 2011 - 2012- University of California (San Francisco)Residency, Radiology-Diagnostic, 2007 - 2011
Santa Clara Valley Medical CenterInternship, Transitional Year, 2006 - 2007
Harvard Medical SchoolClass of 2006
Princeton UniversityAB, Highest Honors, 1998 - 2002
Certifications & Licensure
NY State Medical License 2012 - 2025
CA State Medical License 2008 - 2012- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Neuroradiology
Publications & Presentations
PubMed
- 62 citationsImaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.Sara B. Strauss, Alicia Meng, Edward J. Ebani, Gloria C. Chiang
Radiologic Clinics of North America. 2019-08-16 - 64 citationsNonlinear time course of brain volume loss in cognitively normal and impaired eldersNorbert Schuff, Duygu Tosun, Philip S. Insel, Gloria C. Chiang, Diana Truran
Neurobiology of Aging. 2012-05-01 - 14 citationsThe Added Prognostic Value of Metabolic Tumor Size on FDG‐PET at First Suspected Recurrence of Glioblastoma MultiformeGloria C. Chiang, Naveen Galla, Richard A. Ferraro, Ilhami Kovanlikaya
Journal of Neuroimaging. 2017-03-01
Press Mentions
Grant to Develop Portable PET Scanner for Alzheimer’s DiseaseNovember 5th, 2024
Grant to Help Develop Portable PET Scanner for Alzheimer’sNovember 5th, 2024
A New Spectrum of Biomarkers Emerges for Alzheimer's DiseaseMay 28th, 2024- Join now to see all
Grant Support
- Quantitative Susceptibility Mapping (QSM) as a non-invasive imaging biomarker for predicting neurodegeneration in Alzheimer's DiseaseNational Institutes of Health-National Institute on Aging2020–2022
- Prism-PET/EMMT: High resolution, cost effective, portable, and upright brain PET scanner for early diagnosis of Alzheimer's disease (U01)NIH-NIAPresent
- Tau progression index (TPI): An individualized predictor of Alzheimer's Disease trajectory based on subject-specific connectomes (R01)NIH-NIAPresent
- Quantitative MRI-based cerebral oxygen metabolism in Alzheimer's diseaseNational Institutes of Health - National Institute on AgingPresent
- The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderlyNational Institutes of Health - National Institute on AgingPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
